Aptatek Biosciences is Monitoring Equipment in United States that focus on patented sequences business. Founded in 2008. They cover business area such as developer, an aptamer-base biosensing platform, edge technology, portable disease management device, proprietary aptamer design strategy, patented sequence, novel test, new test strategy, blood test, real-time, diet, phenylalanine level, clinical target, patient compliance, wellness, overall quality, life.
2008
( 16 years old in 2024 )
Patented Sequences
-
Princeton, NJ
United States
Private
developeran aptamer-base biosensing platformedge technologyportable disease management deviceproprietary aptamer design strategypatented sequencenovel testnew test strategyblood testreal-timedietphenylalanine levelclinical targetpatient compliancewellnessoverall qualitylife
* We use standard office opening hours in near Aptatek Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aptatek Biosciences is Monitoring Equipment business from United States that founded in 2008 (16 years old in 2024), Aptatek Biosciences business is focusing on Patented Sequences.
Aptatek Biosciences headquarter office and corporate office address is located in Princeton, NJ United States.
Aptatek Biosciences was founded in United States.
In 2024, Aptatek Biosciences is currently focus on patented sequences sector.
Above is snippet of Google Trends for "patented sequences" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aptatek Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
